Novanta to Acquire Riverpoint Medical, Expanding Medical Portfolio
Reported by Dow Jones Newswires
Sentiment
Neutral
Importance
8
Price
$164.34
Mkt Cap
$5.852B
52W Low
$98.27
52W High
$171.85
Market data snapshot near publication time
Summary
Novanta Inc. announced its acquisition of Riverpoint Medical, a strategic move to expand its product portfolio. This follows the company securing $200 million in new delayed draw term loan commitments on May 15th, which could provide financing for this transaction. The acquisition is expected to enhance Novanta's presence in the medical sector and contribute to future growth.
At the time of this announcement, NOVT was trading at $164.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.9B. The 52-week trading range was $98.27 to $171.85. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
NOVT - Latest Insights
NOVT
Jun 09, 2026, 6:02 AM EDT
Price at Filing:
$164.34
Real-time Price:
$160.87
Change:
-$3.47 (-2%)
Market Cap:
$5.729B
NOVT
Jun 09, 2026, 6:00 AM EDT
Price at Filing:
$164.34
Real-time Price:
$160.87
Change:
-$3.47 (-2%)
Market Cap:
$5.729B
NOVT
May 15, 2026, 4:45 PM EDT
Price at Filing:
$152.99
Real-time Price:
$160.87
Change:
+$7.88 (+5%)
Market Cap:
$5.729B
NOVT
May 11, 2026, 5:00 PM EDT
Price at Filing:
$148.00
Real-time Price:
$160.87
Change:
+$12.87 (+9%)
Market Cap:
$5.729B
NOVT
May 11, 2026, 4:45 PM EDT
Price at Filing:
$139.98
Real-time Price:
$160.87
Change:
+$20.89 (+15%)
Market Cap:
$5.729B
NOVT
Apr 24, 2026, 9:00 AM EDT
Price at Filing:
$133.02
Real-time Price:
$160.87
Change:
+$27.85 (+21%)
Market Cap:
$5.729B
NOVT
Feb 23, 2026, 4:57 PM EST
Price at Filing:
$139.74
Real-time Price:
$160.87
Change:
+$21.13 (+15%)
Market Cap:
$5.729B
NOVT
Feb 23, 2026, 4:45 PM EST
Price at Filing:
$139.74
Real-time Price:
$160.87
Change:
+$21.13 (+15%)
Market Cap:
$5.729B